REVERE PHARMACEUTICALS: all contributions
2025–2026 · Reported individual contributions grouped by employer.
These are contributions by individuals, not by their employer, industry, or location. Refunds remain negative; memo-only rows are marked and are not additional money.
← Back to REVERE PHARMACEUTICALS| # | Reported contributor / location | Reported employer / occupation | Recipient / reporting committee | Date ↕ | Amount ↑ | Election | Filing details / source |
|---|---|---|---|---|---|---|---|
| 1 | SILVERMAN, ROBERTARLINGTONMA02474 | EXECUTIVEREVERE PHARMACEUTICALS | MAD 4 PA PACC00670844 | 2026-06-13 | $5 | General 2026 (G2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1994788FEC filing ↗ |
| 2 | SILVERMAN, ROBERTARLINGTONMA02474 | EXECUTIVEREVERE PHARMACEUTICALS | MAD 4 PA PACC00670844 | 2026-06-30 | $25 | General 2026 (G2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1994788FEC filing ↗ |
| 3 | SILVERMAN, ROBERTARLINGTONMA02474 | EXECUTIVEREVERE PHARMACEUTICALS | MAD 4 PA PACC00670844 | 2026-06-27 | $50 | General 2026 (G2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1994788FEC filing ↗ |
| 4 | SILVERMAN, ROBERTARLINGTONMA02474 | EXECUTIVEREVERE PHARMACEUTICALS | MAD 4 PA PACC00670844 | 2026-04-27 | $50 | General 2026 (G2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1973337FEC filing ↗ |
| 5 | SILVERMAN, ROBERTARLINGTONMA02474 | EXECUTIVEREVERE PHARMACEUTICALS | MAD 4 PA PACC00670844 | 2026-05-27 | $50 | General 2026 (G2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1994788FEC filing ↗ |
| 6 | SILVERMAN, ROBERTARLINGTONMA02474 | EXECUTIVEREVERE PHARMACEUTICALS | MAD 4 PA PACC00670844 | 2026-06-29 | $100 | General 2026 (G2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1994788FEC filing ↗ |
| 7 | SILVERMAN, ROBERTARLINGTONMA02474 | EXECUTIVEREVERE PHARMACEUTICALS | MAD 4 PA PACC00670844 | 2026-04-29 | $100 | General 2026 (G2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1973337FEC filing ↗ |
| 8 | SILVERMAN, ROBERTARLINGTONMA02474 | EXECUTIVEREVERE PHARMACEUTICALS | MAD 4 PA PACC00670844 | 2026-05-29 | $100 | General 2026 (G2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1994788FEC filing ↗ |
| 9 | SILVERMAN, ROBERTARLINGTONMA02474 | EXECUTIVEREVERE PHARMACEUTICALS | MAD 4 PA PACC00670844 | 2026-03-29 | $100 | General 2026 (G2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1963382FEC filing ↗ |
| 10 | SILVERMAN, ROBERTARLINGTONMA02474 | EXECUTIVEREVERE PHARMACEUTICALS | MAD 4 PA PACC00670844 | 2025-10-12 | $500 | General 2026 (G2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1939621FEC filing ↗ |
| 11 | SILVERMAN, ROBERTARLINGTONMA02474 | EXECUTIVEREVERE PHARMACEUTICALS | MAD 4 PA PACC00670844 | 2025-10-12 | $500 | Primary 2026 (P2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1939621FEC filing ↗ |
| 12 | SILVERMAN, ROBERTARLINGTONMA02474 | EXECUTIVEREVERE PHARMACEUTICALS | ACTBLUEC00401224 | 2025-10-12 | $1,000 | Not reported | EARMARKED FOR MAD 4 PA PAC (C00670844)Filing 1953256 · amendedFEC filing ↗ |
| 13 | SILVERMAN, ROBERTARLINGTONMA02474 | EXECUTIVEREVERE PHARMACEUTICALS | ACTBLUEC00401224 | 2025-07-03 | $1,000 | Not reported | EARMARKED FOR MAD 4 PA PAC (C00670844)Filing 1953256 · amendedFEC filing ↗ |
| 14 | SILVERMAN, ROBERTARLINGTONMA02474 | EXECUTIVEREVERE PHARMACEUTICALS | MAD 4 PA PACC00670844 | 2025-07-03 | $1,000 | Primary 2026 (P2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1919502FEC filing ↗ |
| 15 | SILVERMAN, ROBERTARLINGTONMA02474 | EXECUTIVEREVERE PHARMACEUTICALS | MAD 4 PA PACC00670844 | 2025-06-11 | $2,000 | Primary 2026 (P2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1903124FEC filing ↗ |
| 16 | SILVERMAN, ROBERTARLINGTONMA02474 | EXECUTIVEREVERE PHARMACEUTICALS | ACTBLUEC00401224 | 2025-06-11 | $2,000 | Not reported | EARMARKED FOR MAD 4 PA PAC (C00670844)Filing 1909062FEC filing ↗ |
One page is fetched at a time, with one extra row to check for the next page. Current amendment versions are selected before pagination. Raw reported names and filing values are preserved. This list covers locally ingested FEC individual-contribution records, not undisclosed or unitemized contributor identities.